Forsta Ap Fonden Repligen Corp Transaction History

Forsta Ap Fonden

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$120.0 - $182.95 $96,000 - $146,360	800 Added 6.61%	12,900 $1.63 Million
Q1 2024 May 07, 2024	BUY	$170.78 - $208.42 $153,702 - $187,578	900 Added 8.04%	12,100 $2.23 Million
Q4 2023 Feb 06, 2024	SELL	$114.17 - $185.35 $91,336 - $148,280	-800 Reduced 6.67%	11,200 $2.01 Million
Q3 2023 Oct 25, 2023	BUY	$138.78 - $176.51 $1.67 Million - $2.12 Million	12,000 New	12,000 $1.91 Million
Q1 2023 Apr 21, 2023	BUY	$154.26 - $198.1 $2.25 Million - $2.89 Million	14,600 New	14,600 $2.46 Million

488

54.2M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.02B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Forsta Ap Fonden, based on Form 13F filings with the SEC.

Stay updated on Forsta Ap Fonden with notifications on news.